| Literature DB >> 32989016 |
Zesen Lin1, Richard King2, Vi Tang3, Greggory Myers4, Ginette Balbin-Cuesta5,6, Ann Friedman2, Beth McGee2, Karl Desch5,7, Ayse Bilge Ozel8, David Siemieniak9, Pavan Reddy2,5,10, Brian Emmer2, Rami Khoriaty11,4,5,10.
Abstract
Erythropoietin (EPO) stimulates erythroid differentiation and maturation. Though the transcriptional regulation of EPO has been well studied, the molecular determinants of EPO secretion remain unknown. Here, we generated a HEK293T reporter cell line that provides a quantifiable and selectable readout of intracellular EPO levels and performed a genome-scale CRISPR screen that identified SURF4 as an important mediator of EPO secretion. Targeting SURF4 with multiple independent single guide RNAs (sgRNAs) resulted in intracellular accumulation and extracellular depletion of EPO. Both of these phenotypes were rescued by expression of SURF4 cDNA. Additionally, we found that disruption of SURF4 resulted in accumulation of EPO in the endoplasmic reticulum (ER) compartment and that SURF4 and EPO physically interact. Furthermore, SURF4 disruption in Hep3B cells also caused a defect in the secretion of endogenous EPO under conditions mimicking hypoxia, ruling out an artifact of heterologous overexpression. This work demonstrates that SURF4 functions as an ER cargo receptor that mediates the efficient secretion of EPO. Our findings also suggest that modulating SURF4 may be an effective treatment for disorders of erythropoiesis that are driven by aberrant EPO levels. Finally, we show that SURF4 overexpression results in increased secretion of EPO, suggesting a new strategy for more efficient production of recombinant EPO.Entities:
Keywords: CRISPR screen; erythropoiesis; erythropoietin
Mesh:
Substances:
Year: 2020 PMID: 32989016 PMCID: PMC7652404 DOI: 10.1128/MCB.00180-20
Source DB: PubMed Journal: Mol Cell Biol ISSN: 0270-7306 Impact factor: 4.272